Home > Boards > US Listed > Biotechs > Regeneron Pharmaceuticals (REGN)

ART HILL BUY 9/24/18 AT 390.18

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TREND1 Member Profile
Member Level 
Followed By 407
Posts 54,289
Boards Moderated 26
Alias Born 12/16/01
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2020 4:51:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2020 4:50:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2020 4:09:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2020 4:06:31 PM
Sanofi CEO: 'The One-Meeting Trip Will Disappear' Dow Jones News - 4/3/2020 9:29:00 AM
Recession Blue-Chips' Led the Way in Another Turbulent Week in Markets Dow Jones News - 4/3/2020 7:29:00 AM
Dupixent® (dupilumab) Phase 3 Data at Revolutionizing Atopic Dermatitis Conference Show Significant Improvement in Severe At... PR Newswire (US) - 4/3/2020 12:59:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/1/2020 6:50:29 PM
Regeneron Announces American College of Cardiology Presentation of Positive Phase 3 Evinacumab Results in Patients with Sever... PR Newswire (US) - 3/30/2020 11:46:00 AM
First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19 PR Newswire (US) - 3/30/2020 12:59:00 AM
Regeneron Announces Important Advances in Novel COVID-19 Antibody Program PR Newswire (US) - 3/17/2020 7:00:00 AM
Regeneron and Sanofi Start U.S. Studies Assessing Arthritis Drug As Coronavirus Treatment Dow Jones News - 3/16/2020 11:10:00 AM
Regeneron, Sanofi Start Trials for Drug to Treat Covid-19 Dow Jones News - 3/16/2020 8:57:00 AM
Regeneron and Sanofi Begin Global Kevzara® (sarilumab) Clinical Trial Program in Patients with Severe COVID-19 PR Newswire (US) - 3/16/2020 8:09:00 AM
Sanofi and Regeneron begin global Kevzara® (sarilumab) clinical trial program in patients with severe COVID-19 PR Newswire (US) - 3/16/2020 8:00:00 AM
It's a Tough Time to Be in the C-Suite, Good Time to Be in a Gas Field Dow Jones News - 3/13/2020 7:29:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/11/2020 5:00:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/11/2020 4:07:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/11/2020 4:06:26 PM
Regeneron, Sanofi to Test Arthritis Drug as Coronavirus Treatment -- 3rd Update Dow Jones News - 3/10/2020 7:27:00 PM
Regeneron, Sanofi to Test Arthritis Drug as Coronavirus Treatment -- 2nd Update Dow Jones News - 3/10/2020 6:24:00 PM
Biotech Stocks Stumble Despite Broad Market Rally Dow Jones News - 3/10/2020 6:21:00 PM
Regeneron, Sanofi to Test Arthritis Drug as Coronavirus Treatment -- Update Dow Jones News - 3/10/2020 6:00:00 PM
Only 29 Stocks in the S&P 500 Show Gains for the Past Month--Update Dow Jones News - 3/10/2020 5:26:00 PM
Only 19 Stocks in the S&P 500 Are in the Green for the Past Month Dow Jones News - 3/10/2020 4:15:00 PM
TREND1 Member Level  Monday, 09/24/18 08:48:41 PM
Re: None
Post # of 141 
ART HILL BUY 9/24/18 AT 390.18

All my posts are just my opinions. I receive no compensation for
posts. These posts are for entertainment purposes only. I maybe
long or short or hold no position.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist